PE20081892A1 - Nuevos analogos de amino-piridina como agentes antitromboticos - Google Patents
Nuevos analogos de amino-piridina como agentes antitromboticosInfo
- Publication number
- PE20081892A1 PE20081892A1 PE2008000132A PE2008000132A PE20081892A1 PE 20081892 A1 PE20081892 A1 PE 20081892A1 PE 2008000132 A PE2008000132 A PE 2008000132A PE 2008000132 A PE2008000132 A PE 2008000132A PE 20081892 A1 PE20081892 A1 PE 20081892A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- antithrombotic agents
- alkyltio
- cyane
- oxopyrrolidin
- Prior art date
Links
- 239000003146 anticoagulant agent Substances 0.000 title abstract 2
- 229960004676 antithrombotic agent Drugs 0.000 title abstract 2
- 150000003927 aminopyridines Chemical class 0.000 title 1
- -1 PYRIDINE ANALOG COMPOUND Chemical class 0.000 abstract 3
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 2
- DPBWFNDFMCCGGJ-UHFFFAOYSA-N 4-Piperidine carboxamide Chemical compound NC(=O)C1CCNCC1 DPBWFNDFMCCGGJ-UHFFFAOYSA-N 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 102220535958 Dynein axonemal intermediate chain 4_R17S_mutation Human genes 0.000 abstract 1
- 101000740162 Homo sapiens Sodium- and chloride-dependent transporter XTRP3 Proteins 0.000 abstract 1
- 102100037189 Sodium- and chloride-dependent transporter XTRP3 Human genes 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical class [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical class O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical class [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000002441 reversible effect Effects 0.000 abstract 1
- 102200078752 rs201827340 Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
SE REFIERE A UN COMPUESTO ANALOGOS DE PIRIDINA DE FORMULA (I), EN EL QUE R1 ES R7C(O), R17S, R18C(S), ENTRE OTROS; R7 ES ALQUILO C1-C12, ALQUENILO C2-C12, ARILO, HETEROCICLIL(C1-C12)ALQUILSULFONILO, ENTRE OTROS; R17 Y R18 SON CADA UNO ALQUILO C1-C12, HIDROXI(C1-C12)ALQUILO, HETEROCICLILO, ENTRE OTROS; R2 ES C1-C12 ALQUILO, C1-C12 ALCOXI, C1-C12 ALQUILTIO, ENTRE OTROS; R3 ES H, CN, NO2, HETEROCICLIL(C1-C12)ALQUILSULFINILO, ENTRE OTROS; R4 ES NO2, F, C1-C12 ALQUILTIO, ENTRE OTROS; R5 ES H, C1-C12 ALQUILO, CARBOXI(C1-C6)ALQUILO; R14 Y R15 SON CADA UNO H, OH; Rc ES C1-C4 OXOALQUILENO, C2-C4 ALQUINILO, ENTRE OTROS; Rd ES C1-C12 ALQUILO, C3-C8 CICLOALQUILO, ARILO O HETEROARILO; X ES UN ENLACE SIMPLE IMINO(-NH-), METILENO(-CH2-), ENTRE OTROS; Y B ES UN SISTEMA DE ANILLOS DE 4 A 11 MIEMBROS, QUE CONTIENE N, O, S. SON SELECCIONADOS: 1-{5-ACETIL-3-CIANO-6-[(2-OXOPIRROLIDIN-1-IL)METIL]PIRIDIN-2-IL}-N-(BENCILSULFONIL)PIPERIDIN-4-CARBOXAMIDA; N-(BENCILSULFONIL)-1-{5-BUTIRIL-3-CIANO-6-[(2-OXOPIRROLIDIN-1-IL)METIL]PIRIDIN-2-IL}PIPERIDIN-4-CARBOXAMIDA; ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES REVERSIBLES DE P2Y12, UTILES EN EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES Y/O COMO AGENTES ANTITROMBOTICOS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94968707P | 2007-07-13 | 2007-07-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20081892A1 true PE20081892A1 (es) | 2009-02-21 |
Family
ID=40253667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2008000132A PE20081892A1 (es) | 2007-07-13 | 2008-01-11 | Nuevos analogos de amino-piridina como agentes antitromboticos |
Country Status (7)
Country | Link |
---|---|
US (1) | US20090018166A1 (es) |
AR (1) | AR064865A1 (es) |
CL (1) | CL2008000090A1 (es) |
PE (1) | PE20081892A1 (es) |
TW (1) | TW200902513A (es) |
UY (1) | UY30865A1 (es) |
WO (1) | WO2009011627A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090031605A (ko) * | 2006-07-04 | 2009-03-26 | 아스트라제네카 아베 | 신규한 피리딘 유사체 |
US9539246B2 (en) | 2011-08-30 | 2017-01-10 | University Of Utah Research Foundation | Methods and compositions for treating nephrogenic diabetes insipidus |
LT3177612T (lt) | 2014-08-04 | 2022-06-10 | Nuevolution A/S | Pirimidino dariniai, pakeisti pasirinktinai kondensuotu heterociklilu, tinkami uždegiminių, metabolinių, onkologinių ir autoimuninių ligų gydymui |
CN105847191B (zh) * | 2016-03-23 | 2019-03-01 | 华为技术有限公司 | 一种基于重排序算法的交换设备 |
JP2021098692A (ja) | 2019-12-20 | 2021-07-01 | ヌエヴォリューション・アクティーゼルスカブNuevolution A/S | 核内受容体に対して活性の化合物 |
AU2021249530A1 (en) | 2020-03-31 | 2022-12-01 | Nuevolution A/S | Compounds active towards nuclear receptors |
US11780843B2 (en) | 2020-03-31 | 2023-10-10 | Nuevolution A/S | Compounds active towards nuclear receptors |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156758A (en) * | 1999-09-08 | 2000-12-05 | Isis Pharmaceuticals, Inc. | Antibacterial quinazoline compounds |
DK1257550T3 (da) * | 2000-02-04 | 2006-03-27 | Portola Pharm Inc | Blodplade-ADP-receptor-inhibitor |
US6906063B2 (en) * | 2000-02-04 | 2005-06-14 | Portola Pharmaceuticals, Inc. | Platelet ADP receptor inhibitors |
US7132408B2 (en) * | 2000-08-21 | 2006-11-07 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
US7452870B2 (en) * | 2000-08-21 | 2008-11-18 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with P2Y12 receptor antagonist compound |
US7018985B1 (en) * | 2000-08-21 | 2006-03-28 | Inspire Pharmaceuticals, Inc. | Composition and method for inhibiting platelet aggregation |
FR2820057A1 (fr) * | 2001-01-30 | 2002-08-02 | Ct De Transfert De Technologie | Membrane pour chambre d'encapsulation de cellules produisant au moins une substance biologiquement active et organe bio-artificiel comprenant une telle membrane |
AU2002336462A1 (en) * | 2001-09-06 | 2003-03-24 | Millennium Pharmaceuticals, Inc. | Piperazine and homopiperazine compounds |
WO2005035520A1 (en) * | 2003-10-03 | 2005-04-21 | Portola Pharmaceuticals, Inc. | Substituted isoquinolinones |
US7749981B2 (en) * | 2003-10-21 | 2010-07-06 | Inspire Pharmaceuticals, Inc. | Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound |
US7504497B2 (en) * | 2003-10-21 | 2009-03-17 | Inspire Pharmaceuticals, Inc. | Orally bioavailable compounds and methods for inhibiting platelet aggregation |
US7335648B2 (en) * | 2003-10-21 | 2008-02-26 | Inspire Pharmaceuticals, Inc. | Non-nucleotide composition and method for inhibiting platelet aggregation |
AU2005267289A1 (en) * | 2004-06-24 | 2006-02-02 | Incyte Corporation | N-substituted piperidines and their use as pharmaceuticals |
RU2007129779A (ru) * | 2005-01-06 | 2009-02-20 | Астразенека Аб (Se) | Новые соединения пиридина |
AU2006267148A1 (en) * | 2005-07-13 | 2007-01-18 | Astrazeneca Ab | New pyridine analogues |
KR20090031605A (ko) * | 2006-07-04 | 2009-03-26 | 아스트라제네카 아베 | 신규한 피리딘 유사체 |
CA2656597A1 (en) * | 2006-07-04 | 2008-01-10 | Astrazeneca Ab | New pyridine analogues |
TW200811133A (en) * | 2006-07-04 | 2008-03-01 | Astrazeneca Ab | New pyridine analogues III 334 |
KR20090036573A (ko) * | 2006-07-04 | 2009-04-14 | 아스트라제네카 아베 | 신규한 피리딘 유사체 |
-
2008
- 2008-01-11 PE PE2008000132A patent/PE20081892A1/es not_active Application Discontinuation
- 2008-01-11 WO PCT/SE2008/000019 patent/WO2009011627A1/en active Application Filing
- 2008-01-11 CL CL2008000090A patent/CL2008000090A1/es unknown
- 2008-01-11 AR ARP080100130A patent/AR064865A1/es unknown
- 2008-01-11 UY UY30865A patent/UY30865A1/es unknown
- 2008-01-11 TW TW097101233A patent/TW200902513A/zh unknown
- 2008-01-11 US US11/972,787 patent/US20090018166A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090018166A1 (en) | 2009-01-15 |
UY30865A1 (es) | 2009-03-02 |
AR064865A1 (es) | 2009-04-29 |
TW200902513A (en) | 2009-01-16 |
CL2008000090A1 (es) | 2009-01-16 |
WO2009011627A1 (en) | 2009-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20081892A1 (es) | Nuevos analogos de amino-piridina como agentes antitromboticos | |
AR077505A1 (es) | Compuestos de piridina y sus usos | |
AR083070A1 (es) | Analogos de nucleotidos sustituidos con heterociclos nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos para tratar enfermedades virales, en particular infecciones por vhc | |
PE20080318A1 (es) | Derivados de diceto-piperazina y piperidina como agentes antivirales | |
AR062409A1 (es) | Compuesto y composicion farmaceutica, utiles como agentes terapeuticos en el tratamiento, prevencion o mejoramiento de enfermedad o trastorno caracterizado por depositos o niveles de b-amiloide elevados o para inhibir o elucidar la enzima b-secretasa, y proceso para la preparacion del compuesto | |
PE20201165A1 (es) | Analogos de piridazina 1,4-disustituida y metodos para el tratamiento de condiciones relacionadas con la deficiencia de smn | |
DOP2010000046A (es) | Compuestos de biciclolactama sustituida | |
AR049399A1 (es) | Difenilimidazopirimidina e -imidazol aminas como inhibidores de b-secretasa y metodo de obtencion de los mismos | |
AR084768A1 (es) | Moduladores de la senda de complemento y usos de los mismos | |
AR056536A1 (es) | Compuestos de 2-amino-5- [4-(difluormetoxi)fenil]-5-fenilimidazolona como inhibidores de la beta secretasa (bace) | |
AR063684A1 (es) | Derivados de 4, 4´-bifenildiilbis(1h-imidazol-5, 2-diil) como inhibidores del virus de la hepatitis c, composicion que los comprende y su uso para tratar una infeccion con vhc. | |
AR053195A1 (es) | Compuestos inhibidores de dipeptidil peptidasa-iv metodos para preparar los mismos y composiciones farmaceuticas que los contienen como un agente activo | |
PE20080275A1 (es) | Derivados de 5h-benzo[4,5]ciclohepta[1,2]piridina como inhibidores de tirosina quinasa | |
ES2328820T3 (es) | Derivados de 4-(pirazol-3-ilamino)pirimidina para uso en el tratamiento de cancer. | |
PE20141352A1 (es) | Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento | |
PE20160751A1 (es) | Moduladores de tetrahidropiridopirazinas de gpr6 | |
AR079550A1 (es) | Derivados de pirazol | |
PE20051094A1 (es) | Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico y procesos para su preparacion | |
PE20090620A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
PE20090307A1 (es) | Derivados de 7-alquinil-1,8-naftiridonas como agentes inhibidores de vegfr-3 | |
ECSP099216A (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
ATE484502T1 (de) | Neue verbindungen | |
AR066103A1 (es) | Derivados de triazolopiridin - carboxamidas, su preparacion y su aplicacion en terapeutica | |
AR059018A1 (es) | Derivados de 6- fenil -1h- imidazo (4,5-c) piridina -4- carbonitrilo y su uso en el tratamiento de enfermedades relacionadas con catepsina s y/o catepsina k | |
AR068521A1 (es) | Derivados heterociclicos triciclicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |